Inventor · disambiguated record
Taisei Kinoshita
Also filed as: KINOSHITA TAISEI
15 granted patents·10 pending applications·18 citations·filing 2002–2024
88Inventor score
Top patents by PatentIndex Score
25 records- 0178US8334297B22,4-pyrimidinediamine compounds for treatment of inflammatory disordersLI HUI·Filed 2010·Granted Dec 18, 2012·5 cites·26 claims
- 0278US7482351B24-pyrimidineamine compounds and their uses as anti-proliferative agentsRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Jan 27, 2009·2 cites·20 claims
- 0369US12018032B2Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interactionBIOMEA FUSION INC·Filed 2022·Granted Jun 25, 2024·0 cites·19 claims
- 0468US8377945B2Small molecule inhibitors of spleen tyrosine kinase (SYK)RIGEL PHARMACEUTICALS INC·Filed 2010·Granted Feb 19, 2013·1 cites·26 claims
- 0568US7563585B2Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)RIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jul 21, 2009·0 cites·11 claims
- 0667US6979549B2Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 proteinRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Dec 27, 2005·5 cites·52 claims
- 0767US2008003620A1Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinaseRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 0866US7598050B2Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 proteinRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Oct 6, 2009·1 cites·14 claims
- 0964US8575165B2Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compoundsGURURAJA TARIKERE·Filed 2010·Granted Nov 5, 2013·2 cites·3 claims
- 1064US7422867B2Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 proteinRIGEL PHARMACEUTICALS INC·Filed 2007·Granted Sep 9, 2008·0 cites·11 claims
- 1162US2009093494A14-Pyrimidineamine Compounds And Uses As Anti-Proliferative AgentsRIGEL PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1261US2024343731A1Crystalline forms of an irreversible inhibitor of menin-mll interactionBIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 1360US7378251B2Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa proteinRIGEL PHARMACEUTICALS INC·Filed 2002·Granted May 27, 2008·2 cites·28 claims
- 1460US7241581B2Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC proteinRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Jul 10, 2007·0 cites·20 claims
- 1560US2007135350A1Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing a B-Cell Associated ProteinRIGEL PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1659US7141434B2Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinaseRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Nov 28, 2006·0 cites·27 claims
- 1759US2007054862A1Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing an Adenosine KinaseRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1855US7208289B2Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 proteinRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Apr 24, 2007·0 cites·26 claims
- 1955US2008003618A1Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a b-cell associated proteinRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2054US2020030330A1Bruton's tyrosine kinase inhibitor combinations and uses thereofPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 2154US2007244033A1Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a c-myc proteinRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2251US2017027941A1Bruton's Tyrosine Kinase Inhibitor Combinations and Uses ThereofPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 2350US7189523B2Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated proteinRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Mar 13, 2007·0 cites·29 claims
- 2449US7374894B2Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 proteinRIGEL PHARMACEUTICALS INC·Filed 2002·Granted May 20, 2008·0 cites·28 claims
- 2541US2006160869A1Ubiquitin ligase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Taisei Kinoshita files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →